-
Study aim
-
Prevention of reduction in renal function after percutaneous nephrolithotomy.
Improvement in renal function after percutaneous nephrolithotomy.
To compare complications of percutaneous nephrolithotomy in case and control groups
-
Design
-
Randomised clinical trial including 75 patients in 2 parallel case and control groups ; triple blinded (patients , surgeon and data analyzer were all blind),Randomised with balanced block randomization table.
-
Settings and conduct
-
150 patients 18-75 years of age who are candidates for percutaneous nephrolithotomy (PCNL) referring to Hasheminejad Kidney Center will be randomly divided into 2 groups of 75 patients. In the intervention group 15 minutes before surgery 25 g intravenous mannitol will be injected. In the control group no mannitol will be injected. Glomerular filtration rate (GFR) will be measured using the cockroft gault equation based on creatinine levels on the day before surgery, 6 hours after surgery, 1, 2, and 14 days after surgery. In this study, the surgeon, the static analyzer, the data collector, and the patients will be blinded to injection of mannitol.
-
Participants/Inclusion and exclusion criteria
-
Patients candiate for percutaneous nephrolithotomy between 18 to 75 years old; without history of deep vein thrombosis, emboli, brain edema, high intracranial pressure, digoxin user, and lithium user, coagolopathies, Heart failure
-
Intervention groups
-
In case group, 15 minutes before percutaneous nephrolithotomy, 25 grams of mannitol solution will be injected intravenously.
In control group, non mannitol serum will be injected.
-
Main outcome variables
-
Glomerular filtration rate changes, Serum hemoglobin level changes, Complications of the surgery in both groups